By contrast, the frequency of alterations in the PRKAA2 gene (encoding α2) in cancer is lower overall (Fig. 3C; note the different scales), and there is no obvious bias towards gene amplification or increased mRNA expression (Fig. 5C). The gene discussed is PRKAA2; the disease is cancer.